palmidrol has been researched along with Coronary Artery Disease in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quercioli, A | 1 |
| Carbone, F | 1 |
| Bonaventura, A | 1 |
| Liberale, L | 1 |
| Pataky, Z | 1 |
| Thomas, A | 1 |
| Lenglet, S | 1 |
| Lauer, E | 1 |
| Golay, A | 1 |
| Dallegri, F | 1 |
| Di Marzo, V | 1 |
| Schindler, TH | 1 |
| Montecucco, F | 1 |
1 other study available for palmidrol and Coronary Artery Disease
| Article | Year |
|---|---|
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function.
Topics: Amides; Biomarkers; Body Mass Index; Chromatography, Liquid; Coronary Artery Disease; Coronary Circu | 2017 |